Compare CYRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYRX | SENS |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 308.5M |
| IPO Year | 2008 | 2014 |
| Metric | CYRX | SENS |
|---|---|---|
| Price | $8.04 | $6.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $12.94 | ★ $22.70 |
| AVG Volume (30 Days) | 398.8K | ★ 498.0K |
| Earning Date | 03-03-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | $16,389,000.00 |
| Revenue This Year | $10.92 | $70.20 |
| Revenue Next Year | $8.08 | $59.10 |
| P/E Ratio | $5.94 | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $4.63 | $0.41 |
| 52 Week High | $11.45 | $8.75 |
| Indicator | CYRX | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 44.92 |
| Support Level | $8.01 | $5.41 |
| Resistance Level | $8.45 | $8.55 |
| Average True Range (ATR) | 0.53 | 0.52 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 24.57 | 43.77 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.